Why Does Cannabis Help Anxiety if it Increases Paranoia?
The Marijuana Times - By. Julia Granowicz - 09/29/2016
In the United States alone, 40 million people every year suffer from some sort of anxiety-related disorder – whether it be Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder or Post-Traumatic Stress Disorder – and all of them have the potential to be a debilitating illness. As it stands, there are more people suffering from anxiety related mental illnesses than there are people suffering from arthritis, which is the most common cause of chronic pain. Unfortunately, anxiety is one of those conditions that can be hard to get under control.
The pharmaceutical industry profits every year by prescribing anti-depressant and anti-anxiety drugs – but each year more and more people are turning to safer and more effective alternatives, especially medical marijuana. It may seem ironic – using a plant that is said to induce paranoia to reduce the feelings of paranoia – but it really does work for a large number of patients. This comes down to the fact that patients aren’t using cannabis to get stoned, they are using it to feel normal again – something some medications simply can’t do for many people.
For many, the motivation to give medical marijuana a try stems from the fact that they simply cannot stand to be on the medications they have already been prescribed. Many physicians will prescribe anti-depressant drugs as a treatment for anxiety disorders – even if depression isn’t necessarily the cause of the anxiety. These medications may work for some, but in many the side effects are worse than the original symptoms of anxiety; some common side effects including fatigue, dizziness, lightheadedness and some as scary as numbness and tingling in the extremities, hallucinations and even thoughts of suicide (this last one is most common in teens).
The fact that it is impossible to overdose on cannabis and the side effects are so few (dry mouth and dry eyes being the most common and paranoia, fatigue, increased appetite and more will vary by strain) that it has become an attractive option for patients who are tired of feeling worse on their medication than they do off of it. The biggest issue becomes: what kind of medical marijuana should be used when treating anxiety disorders? There are definitely some that are more likely to produce a paranoid feeling after consumption and clearly those are strains that someone with anxiety will want to avoid. So why, if cannabis can make some people paranoid, can it also be an excellent treatment option for a condition like anxiety?
Turning to Medical Marijuana for Anxiety Disorders
When choosing medical marijuana as a treatment option for anxiety disorders, you should take into consideration the fact that what works best for one person, may not be exactly what you need. Someone who has been using cannabis to manage their anxiety for years may have built up a tolerance and may benefit from slightly higher THC strains – however, new patients, especially those who are not accustomed to cannabis, should start off with lower THC strains until they know how their body and mind will react to the medicine.
Smoking and vaporizing is an excellent remedy when you need something fast-acting. If you find that you only need medication when things are becoming too much or you can feel a panic attack coming on, then you may want to stick to these forms of consumption. With smoking and vaping you will find the effects are almost immediate – so there will not be a long wait for your overwhelming feelings to subside; however, if you were to choose edibles instead than you may find that the effects take a couple of hours for onset (making them best for using prior to putting yourself in a stressful situation that could trigger your anxiety).
You should also take into consideration the fact that there are other forms of medical cannabis rather than just raw cannabis flowers – you can choose to medicate with oils as well as choosing to use the isolated compound cannabidiol (CBD), which is proven to be effective for both anxiety disorders and depression. There are many people who find that CBD alone is enough to treat their anxiety and help them to once again lead a productive life.
A study back in 2011 was conducted on a small group (only 10 people) who were diagnosed with Social Anxiety Disorder (SAD). In the first half of the study, one group of 5 received 400 mg of CBD, while the other group received a placebo. During the second half of the study they reversed and the 5 who previously received CBD now got the placebo and vice versa – and the results of that study were extremely promising. It showed that there was a significant decrease in subjective anxiety – determined by the cerebral blood flow after being administered the CBD.
The fact that CBD has many of the same healing properties as THC without the high is the main reason it has become a highly regarded cannabinoid in the world of medical marijuana. In fact, even some states who refuse to legalize medical marijuana have created laws that allow the use of CBD-only products for seizure conditions; with more studies, depression and anxiety might not be far behind.
Choosing Your Strains Wisely
While CBD may be helpful on it’s own for a number of people, the most convenient (and least expensive) form of medicating with cannabis is generally to utilize cannabis flowers in the form of smoking or vaping, but that doesn’t mean that you can’t still get all the benefits of a CBD-based medication – you just have to be careful when you pick the strains you choose to medicate with. Strains that are higher in CBD and lower in THC are optimal for people suffering from anxiety disorders.
If a strain that is higher in CBD than THC is not readily available to you, then you will want to do your best to stick to indica and indica dominant hybrids as they generally have a higher CBD content than sativa strains do. It is actually the sativa strains that are most likely to induce paranoia – though this seems to be a reaction more in occasional and new users, rather than people who use cannabis frequently. Reducing the possibility of these feelings can be done in most cases by choosing an indica strain instead, which is know for relaxing sedation, rather than being euphoric and energizing.
Cannabis may be a complicated plant, but the growing understanding of our endocannabinoid system helps us to understand how to better utilize medical marijuana for mental health conditions like anxiety and depression. While CBD may be a perfectly effective treatment, it often works best in conjunction with small amounts of THC (as it occurs naturally in high CBD strains like Charlotte’s Web and Harlequin). As it turns out, people suffering from anxiety, depression and other mental illnesses may actually be lacking in naturally occurring endocannabinoids, which seems to be balanced out with the introduction of moderate doses of cannabis.
The biggest problem, aside from deciding which strains work best, is always going to be dosage. It is difficult to determine exactly what a proper dose of cannabis is – especially since everyone will react slightly differently. Some people may be more likely to be predisposed to paranoia as a cannabis side effect, while others may never experience this feeling; and it only takes a couple extra puffs or a slightly too-strong edible to send your experience down the drain. Moderation is key when it comes to cannabis treatments – in many cases, less really is more.
In the end, the bottom line is, too much cannabis, especially strains that are particularly high in THC, are more likely to cause you a bout of paranoia. New and infrequent users are also more likely to see this effect when compared to people who use cannabis more regularly. If you are intending to use cannabis as an alternative treatment for anxiety disorders then you should know going in that the best strains are those high in CBD and low in THC (the kind that generally won’t get you high) and that CBD on it’s own (if made from medical cannabis, not the hemp version) can also be an effective and non-psychoactive treatment option to consider.
It takes experimentation for everyone to find exactly what works right for them – while one person may find that 2-3 puffs of Blue Dream is exactly what they need to get through the day, others may find that to be too much and prefer a CBD only medication (or at least one with only trace amounts of THC). Until the day comes when we are able to do massive scale trials with medical marijuana, experimentation will be the only way for patients to determine exactly what works for them – but then again, even with pharmaceuticals there is trial and error involved just to get the right prescription and dosage; at least with medical marijuana switching dosages and strains cannot cause you the type of health problems prescription drugs changes could.
Arizona Could Be First To OK Marijuana For Depression, Anxiety
The Arizona Department Of Health Services Will Review Petitions To Add Four New Debilitating Conditions To Medical Marijuana Program
By Staff Report
Modern Times Magazine
April 21, 2012 — Arizona would become the first state in the U.S. to approve marijuana use for depression and anxiety if petitions requesting the addition of the conditions are approved later this summer, according to Will Humble, director of the Arizona Department of Health Services.
“The voter approved language in the AZ Medical Marijuana Act directs us to periodically accept and evaluate petitions to add new debilitating medical conditions. We’ve made it through the first phase of considering whether to add four new debilitating conditions,” Humble posted on his official blog Friday. “Post-traumatic stress disorder; generalized anxiety disorder; migraines; and depression.”
New Mexico and Delaware are the only states that permit medical marijuana for post-traumatic stress disorder. California is the only other state that permits medical marijuana for migraines.
Humble posted Friday afternoon that a public hearing would be begin at 1 p.m., May 25, in the State Lab, 250 N. 17th Avenue, Phoenix. The public hearing is the next stage for the four petitions requesting that four conditions be added the list of debilitating conditions that were passed by voters by way of Prop. 203 in Nov. 2010. The resulting Arizona Medical Marijuana Act also created a regular acceptance protocol for petitions to the department of health services, or DHS. The four potential additions were filed with the DHS in January.
According to the Arizona Medical Marijuana Act, the DHS has 180 days to review the petitions and to approve or deny the application. In order to schedule a public hearing, the DHS must determine that the condition can impair one’s daily life and that it has been cited that marijuana is efficacious to the treatment of the condition. Since the DHS restricted petition submittal to Jan. 23 to 27, the deadline for the state to act on them is sometime during the last week of June.
Humble said in his blog that his department will consult the highest levels of the medical community before reaching a final decision.
“If we decide to add PTSD or any other debilitating conditions, we want to make sure we’re on solid medical ground. I’m heading down to a conference in Tucson next weekend where physicians can get Continuing Medical Education credits for learning about medical cannabis,” Humble posted.
The conference to which Humble was referring is The National Clinical Conference On Cannabis Therapeutics. The conference is in its seventh year and will be held April 26 to 28 at Loews Ventana Canyon Resort in Tucson.
According to the DHS petition information, the department is also working with the University of Arizona, Colleges of Public Health and Medicines to review the petitions.
“The University will be able to provide ADHS valuable support, including further research of each condition or treatment and summary reports with recommendations by accessing its extensive public health and medical expertise,” according to the DHS website.
Current accepted conditions include: cancer; glaucoma; human immunodeficiency virus; acquired immune deficiency syndrome; Hepatitis C; ALS, Crohn's disease; agitation of Alzheimer's disease; cachexia or wasting syndrome; severe and chronic pain; severe nausea; epilepsy; and severe or persistent muscle spasms, including those characteristic of multiple sclerosis.
May will be a busy month for the DHS, as it announced earlier this month that it will begin accepting dispensary applications May 14.